Articles
Unending tort liability for innovators
December 22, 2017 | By DEBORAH LA FETRA
In 2007, the expectant mother of twins used a generic form of an asthma medication for the off-label purpose of preventing pre-term labor. Novartis innovated, developed and manufactured the brand-name version of the medication, then sold its rights to the product in 2001. The twins were diagnosed with autism in 2012, allegedly tied to the medicatio ...